Department of Medicine, Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada.
University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Am Coll Cardiol. 2022 Aug 2;80(5):545-561. doi: 10.1016/j.jacc.2022.06.002.
Bioprosthetic valve dysfunction (BVD) and bioprosthetic valve failure (BVF) may be caused by structural or nonstructural valve dysfunction. Both surgical and transcatheter bioprosthetic valves have limited durability because of structural valve deterioration. The main objective of this summary of experts participating in a virtual workshop was to propose standardized definitions for nonstructural and structural BVD and BVF following aortic or mitral biological valve replacement with the goal of facilitating research reporting and implementation of these terms in clinical practice. Definitions of structural BVF, based on valve reintervention or death, underestimate the true incidence of BVF. However, definitions solely based on the presence of high transprosthetic gradient at a given echocardiogram during follow-up overestimate the incidence of structural BVD and BVF. Definitions of aortic or mitral structural BVD must therefore include the confirmation by imaging of permanent structural changes to the leaflets alongside evidence of deterioration in valve hemodynamic function at echocardiography follow-up.
生物瓣功能障碍(BVD)和生物瓣衰竭(BVF)可能由结构性或非结构性瓣功能障碍引起。由于结构性瓣膜退化,外科和经导管生物瓣的耐用性均有限。本专家参与虚拟研讨会的摘要主要目的是提出主动脉瓣或二尖瓣生物瓣置换后非结构性和结构性 BVD 和 BVF 的标准化定义,以促进研究报告和在临床实践中应用这些术语。基于瓣膜再介入或死亡的结构性 BVF 定义低估了 BVF 的真实发生率。然而,仅基于随访期间某次超声心动图上跨瓣压差升高的定义会高估结构性 BVD 和 BVF 的发生率。因此,主动脉瓣或二尖瓣结构性 BVD 的定义必须包括影像学确认瓣叶的永久性结构改变,以及超声心动图随访时瓣膜血流动力学功能恶化的证据。